toggle menu

Board Decisions

GF/B33/EDP01

Approved by the Board on:
15 May 2015

Decision on the Secretariat’s Recommendation on Additional Funding from the 2014 Allocation

The Board:

  1. Approves the incremental funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of Annex 1 to GF/B33/ER01;
  2. Approves the reinvestment of newly identified existing funds for the Ukraine TB/HIV program and its constituent grants and its resultant total program budget, as listed in Table 2 of Annex 1 to GF/B33/ER01;
  3. Acknowledges each country disease component's constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with the Global Fund policies;
  4. Affirms the incremental funding approved under this decision (a) increases the upper-ceiling amount that may be available for the relevant implementation period of each country disease component's constituent grants, (b) is subject to the availability of funding, and (c) shall be committed in annual tranches; and
  5. Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the "TRP") validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.

This decision does not have material budgetary implications for the 2015 Operating Expenses Budget.

Annex: Armenia TB - Ministry of Health of the Republic of Armenia (ARM-T-MOH), Bhutan - TB - Ministry of Health of Bhutan (BTN-T-MOH), Costa Rica - HIV - Humanist Institute for Cooperation (HIVOS) (CRI-H-HIVOS), Eritrea - Malaria - Ministry of Health of Eritrea (ERI-M-MOH), Iraq - TB - UNDP (IRQ-T-UNDP), UKR-C-AUA, UKR-C-AUN, UKR-C-UCDC.

Notes

A register of the Board's Funding Decisions is available here.

  • Related Documents:

We are using cookies to enhance the user experience on this website. By continuing on this website, you accept the use of cookies.